TEVA | Market Realist
Teva faces US marketing investigation - PMLiVE
Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Teva subsidiary opens $100m manufacturing facility in Croatia
Teva's Adderall Shortage Expected to Continue Into March, FDA Says - BNN Bloomberg
Teva entered the FDA's shame list
Teva tumbles as sales and earnings underwhelm
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ELYBYTG4QZMUJPXRYDKAVNSTAI.jpg "New branded drugs helping Teva Pharm move closer to growth | Reuters")
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva files potential blockbuster migraine drug for FDA approval
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
Teva expects FDA preapproval inspection of troubled Celltrion plant this year | Fierce Pharma
Teva wins FDA OK for crucial migraine drug - PMLiVE
ADDING MULTIMEDIA Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ (albuterol sulfate 117 mcg) Inhalation Powder | Business Wire
FDA clears Teva's tardive dyskinesia drug Austedo - PMLiVE
Teva Doubles Production as Japanese Change Attitude to Generics
US FDA accepts Teva-MedinCell's NDA for drug to treat schizophrenia
Teva puts the brakes on troubled California sterile injectables plant: reports | Fierce Pharma
Teva Pursues Regulatory Approval in Japan for MS Drug Copaxone
Teva recalls seizure drug | Fierce Pharma
Teva-Takeda joint venture divests certain assets in Japan to Nichi-Iko - Pharmaceutical Technology
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
FDA Approves Teva's Generic Version of EpiPen Injector - WSJ
Teva's Key Drugs in Its Specialty Products Pipeline
